This inventor holds 1 USPTO granted patent and 4 published patent applications. Active years: 2026.
Years Active: 2026
Title: Shon K Booker: Innovator in Macrocyclic Compounds
Introduction
Shon K Booker is a notable inventor based in Sherman Oaks, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of macrocyclic compounds. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Latest Patents
Shon K Booker holds a patent for "Macrocyclic compounds and methods of use." This patent provides compounds that are useful for the inhibition of various KRAS mutations, including G12D, G12V, G12A, G12S, G13D, Q61H, Q61L, and G12C. The compounds are described by a general Formula I′, with specific variables defined within the patent. Additionally, the disclosure includes pharmaceutical compositions that incorporate these compounds, highlighting their potential applications in cancer treatment.
Career Highlights
Throughout his career, Shon K Booker has demonstrated a strong focus on innovation in the pharmaceutical industry. His research has led to the development of compounds that could significantly impact cancer therapies. With a patent count of 1 patent, he continues to contribute to the scientific community through his inventive work.
Collaborations
Shon K Booker has collaborated with talented individuals such as Ryan Paul Wurz and Yunxiao Li. These partnerships have enhanced his research efforts and contributed to the successful development of his patented compounds.
Conclusion
Shon K Booker is an influential inventor whose work in macrocyclic compounds holds promise for cancer treatment. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical field.